Cargando…
RF07 | PSUN384 Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with a 18% 5-year survival rate. Mice lacking the splicing factor SRSF3 in hepatocytes (SKO mice) overexpress IGF2 and are predisposed to developing HCC with age. Loss of Igf2 in the SKO background prevented hepatic fibrosis an...
Autores principales: | Das, Manasi, Ellies, Lesley, Jih, Lily, Kumar, Deepak, Oberg, Alexis, Sahoo, Debashis, Sauceda, Consuelo, Webster, Prof Nicholas, Wu, Panyisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628777/ http://dx.doi.org/10.1210/jendso/bvac150.1857 |
Ejemplares similares
-
Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma
por: Kumar, Deepak, et al.
Publicado: (2022) -
MON-314 Insulin-like Growth Factor 2 Drives Hepatocellular Carcinoma In Hepatocyte Srsf3 Ko Mice
por: Kumar, Deepak, et al.
Publicado: (2019) -
RF07 | PSUN359 Alpelisib-induced Diabetic Ketoacidosis
por: Majumdar, Sachin, et al.
Publicado: (2022) -
RF07 | PSUN366 An Uncommon Path Leading to Diagnosis of Multiple Endocrine Neoplasia 2A
por: Gokul, Sagarika, et al.
Publicado: (2022) -
RF07 | PSUN356 Synergistic Combination of HSP90 and PI3K inhibitors in Adrenocortical Cancer
por: Mishra, Prachi, et al.
Publicado: (2022)